Nasdaq News

Key PointsApple is on a roll, almost doubling the market's return this year.

Key PointsConcerns are growing around how engaged Netflix customers are.

Key PointsThe Invesco QQQ ETF (QQQ) has one of the best track records of the past several years.

(RTTNews) - AbbVie (ABBV) announced the FDA has approved JUVMO tablets as the first and only selective D1/D5 receptor agonist for the treatment of adults with Parkinson's disease. The approval is supported by the Phase 3 TEMPO program. AbbVie expects to make JUVMO available to pa

Fintel reports that on September 28, 2026, Seaport Global initiated coverage of Jack Henry & Associates (NASDAQGS:JKHY) (BIT:1JKHY) with a Buy recommendation.Jack Henry & Associates, Inc., based in the United States, is an esteemed provider within the financial technology

Key PointsTilray's earnings have been volatile in the past due to acquisitions and impairment charges.

(RTTNews) - Energy supply concerns are still ruining market sentiments and early signs from the U.S. Futures Index point to lower open for Wall Street on Monday.

(RTTNews) - Ramaco Resources Inc. (METC, METCB, METCI, METCZ), a mining company, on Monday announced that a federal jury awarded $30 million in damages to its subsidiary Ramaco Resources LLC.

(RTTNews) - NVIDIA (NVDA), a semiconductor company, announced Monday the launch of the NVIDIA Open Agent Safety Platform. The platform is an open software solution and reference system design intended to strengthen AI security from agent testing through deployment, with full-stac

(RTTNews) - Psyence Biomedical Ltd. (PBM) shares moved higher in pre-market after the company announced a deal that could strengthen its position in the emerging field of ibogaine-based drug development in the United States.

Key PointsThe Vanguard S&P 500 ETF grew investor capital more than fourfold over the last 10 years.

Key PointsDell is poised to capitalize on strong AI server shipments, higher average selling prices, and an improving market share.

(RTTNews) - Merck & Co., Inc. (MRK), an American multinational pharmaceutical company, announced on Monday that it has entered into an exclusive global license agreement with SciBrunch Therapeutics for SPR2015, an investigational preclinical oral KRAS G12D (ON) inhibitor.

Key PointsLucid continues to focus on the high-end luxury market with a significant vehicle purchase agreement from the Government of Saudi Arabia.

The S&P 500 Index ($SPX ) (SPY ) closed up by +0.51% on Friday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.93%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.42%. December E-mini S&P futures (ESZ26 ) rose +0.47%, and December E-mini...

(RTTNews) - CervoMed Inc. (CRVO) announced pharmacokinetic, regulatory, and manufacturing advances for neflamapimod, including a new 50 mg oral tablet formulation and the FDA's removal of a previous plasma drug exposure limit.

The S&P 500 Index ($SPX ) (SPY ) closed up by +0.51% on Friday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.93%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.42%. December E-mini S&P futures (ESZ26 ) rose +0.47%, and December E-mini...

Key PointsIonQ and Quantinuum are leading the charge on accuracy using the trapped-ion technique.

Key PointsAnthropic could become the biggest IPO ever, following its anticipated October debut.

Key PointsSocial Security’s highly anticipated cost-of-living adjustment (COLA) will be revealed on Oct. 14.